Awarded
Lote 284: Reslizumab 25 Mg Vial 2,5 Ml Perfusion Intravenosa
Track this recordFree account — get alerted when a contract here runs out.
- Winners
- TEVA PHARMA, S.L.
- Contract value
- €112,002
- Bids received
- 1
- Published
- 10 Oct 2025
- Awarded
- 10 Sept 2025
- Contract start
- 10 Sept 2025
- Contract end
- 11 Sept 2026estimated
- Region
- Tenerife